Abstract
Enkephalin markedly attenuates a variety of GABAergic inhibitory pathways in the CNS, but does not affect the action of GABA. The action of enkephalin is reversed by the specific opiate antagonist, naloxone. Thus, inhibitory interneurones may be primary targets for opioid peptide-containing pathways and disinhibition may be of general importance for opioid peptide action in the CNS.
Original language | English (US) |
---|---|
Pages (from-to) | 22-25 |
Number of pages | 4 |
Journal | Nature |
Volume | 287 |
Issue number | 5777 |
DOIs | |
State | Published - 1980 |
Externally published | Yes |
ASJC Scopus subject areas
- General